Pure Health Holding PJSC

PUREHEALTHStocksAbu Dhabi Securities ExchangeHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual (AED)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	27.31B	25.85B	16.40B	12.49B
Cost of Revenue	20.58B	19.20B	12.98B	7.66B
Gross Profit	6.73B	6.65B	3.42B	4.83B
SG&A	4.78B	4.67B	2.76B	2.33B
Operating Expenses	4.07B	4.35B	1.92B	0.95B
Operating Income	2.67B	2.29B	1.50B	3.88B
Interest Income	340.31M	304.05M	—	—
Interest Expense	-852.69M	-825.28M	-78.22M	-44.56M
Other Income/Expense	-12.16M	-22.36M	-39.26M	—
Pretax Income	2.24B	1.78B	1.38B	4.29B
Income Tax	222.01M	62.04M	418.70M	—
Net Income	2.00B	1.71B	0.96B	3.72B
EBITDA	3.53B	3.16B	2.22B	4.17B
EBIT	2.67B	2.29B	1.50B	3.88B
EPS (Basic)	0.18	0.15	0.10	0.38
EPS (Diluted)	0.18	0.15	0.10	0.38
DPS	—	0.03	—	—
Margins & Efficiency
Gross Margin %	+24.7%	+25.7%	+20.9%	+38.7%
EBITDA Margin %	+12.9%	+12.2%	+13.5%	+33.4%
Net Margin %	+7.3%	+6.6%	+5.9%	+29.8%
Revenue & Income
Revenue	27.31B	25.85B	16.40B	12.49B
Revenue Growth (YoY)	+5.7%	+57.6%	+31.3%	—
Interest & Investment Income	340.31M	304.05M	—	—
Gain (Loss) on Sale of Assets	12.23M	25.37M	-0.61M	-19.11M
Gain (Loss) on Sale of Investments	43.90M	68.18M	—	—
Expenses & Provisions
Cost of Revenue	20.58B	19.20B	12.98B	7.66B
Selling, General & Admin	4.78B	4.67B	2.76B	2.33B
Operating Expenses	4.07B	4.35B	1.92B	0.95B
Other Operating Expenses	-0.71B	-0.32B	-0.84B	-1.38B
Interest Expense	-852.69M	-825.28M	-78.22M	-44.56M
Other Non Operating Income (Expenses)	-12.16M	-22.36M	-39.26M	—
Asset Writedown	43.34M	-65.84M	—	-7.01M
Impairment of Goodwill	—	—	—	-265.00K
D&A For EBITDA	863.47M	870.94M	719.19M	284.93M
Profitability & Returns
Gross Profit	6.73B	6.65B	3.42B	4.83B
Gross Margin	+24.7%	+25.7%	+20.9%	+38.7%
EBIT	2.67B	2.29B	1.50B	3.88B
EBIT Margin	+9.8%	+8.9%	+9.2%	+31.1%
EBITDA	3.53B	3.16B	2.22B	4.17B
EBITDA Margin	+12.9%	+12.2%	+13.5%	+33.4%
EBT Excluding Unusual Items	2.14B	1.75B	1.38B	3.84B
Pretax Income	2.24B	1.78B	1.38B	4.29B
Operating Income	2.67B	2.29B	1.50B	3.88B
Operating Margin	+9.8%	+8.9%	+9.2%	+31.1%
Profit Margin	+7.3%	+6.6%	+5.9%	+29.8%
Net Income	2.00B	1.71B	0.96B	3.72B
Net Income to Common	2.00B	1.71B	0.96B	3.72B
Net Income Growth	+17.0%	+77.4%	-74.1%	—
Earnings From Continuing Ops.	2.02B	1.72B	0.96B	4.29B
Minority Interest in Earnings	-17.99M	-4.09M	-0.29M	-567.45M
Income Tax Expense	222.01M	62.04M	418.70M	—
Effective Tax Rate	+9.9%	+3.5%	+30.3%	—
Per Share & Capital
EPS (Basic)	0.18	0.15	0.10	0.38
EPS (Diluted)	0.18	0.15	0.10	0.38
EPS Growth	+17.0%	+60.3%	-74.6%	—
Dividend Per Share	—	0.03	—	—
Shares Change (YoY)	-0	0.11	0.02	—
Shares Outstanding (Basic)	11.11B	11.11B	10.04B	9.83B
Shares Outstanding (Diluted)	11.11B	11.11B	10.04B	9.83B
Free Cash Flow	3.99B	3.44B	2.14B	3.96B
Free Cash Flow Margin	+14.6%	+13.3%	+13.1%	+31.7%
Free Cash Flow Per Share	0.36	0.31	0.21	0.40
Payout Ratio	+17.5%	—	+31.1%	+82.2%
Supplemental
Other Unusual Items	0.80M	—	—	475.46M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (AED)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operating Summary
Revenue	27.31B	25.85B	16.40B	12.49B
Cost of Revenue	20.58B	19.20B	12.98B	7.66B
Gross Profit	6.73B	6.65B	3.42B	4.83B
SG&A	4.78B	4.67B	2.76B	2.33B
Operating Expenses	4.07B	4.35B	1.92B	0.95B
Operating Income	2.67B	2.29B	1.50B	3.88B
Interest Income	340.31M	304.05M	—	—
Interest Expense	-852.69M	-825.28M	-78.22M	-44.56M
Other Income/Expense	-12.16M	-22.36M	-39.26M	—
Pretax Income	2.24B	1.78B	1.38B	4.29B
Income Tax	222.01M	62.04M	418.70M	—
Net Income	2.00B	1.71B	0.96B	3.72B
EBITDA	3.53B	3.16B	2.22B	4.17B
EBIT	2.67B	2.29B	1.50B	3.88B
EPS (Basic)	0.18	0.15	0.10	0.38
EPS (Diluted)	0.18	0.15	0.10	0.38
DPS	—	0.03	—	—
Margins & Efficiency
Gross Margin %	+24.7%	+25.7%	+20.9%	+38.7%
EBITDA Margin %	+12.9%	+12.2%	+13.5%	+33.4%
Net Margin %	+7.3%	+6.6%	+5.9%	+29.8%
Revenue & Income
Revenue	27.31B	25.85B	16.40B	12.49B
Revenue Growth (YoY)	+5.7%	+57.6%	+31.3%	—
Interest & Investment Income	340.31M	304.05M	—	—
Gain (Loss) on Sale of Assets	12.23M	25.37M	-0.61M	-19.11M
Gain (Loss) on Sale of Investments	43.90M	68.18M	—	—
Expenses & Provisions
Cost of Revenue	20.58B	19.20B	12.98B	7.66B
Selling, General & Admin	4.78B	4.67B	2.76B	2.33B
Operating Expenses	4.07B	4.35B	1.92B	0.95B
Other Operating Expenses	-0.71B	-0.32B	-0.84B	-1.38B
Interest Expense	-852.69M	-825.28M	-78.22M	-44.56M
Other Non Operating Income (Expenses)	-12.16M	-22.36M	-39.26M	—
Asset Writedown	43.34M	-65.84M	—	-7.01M
Impairment of Goodwill	—	—	—	-265.00K
D&A For EBITDA	863.47M	870.94M	719.19M	284.93M
Profitability & Returns
Gross Profit	6.73B	6.65B	3.42B	4.83B
Gross Margin	+24.7%	+25.7%	+20.9%	+38.7%
EBIT	2.67B	2.29B	1.50B	3.88B
EBIT Margin	+9.8%	+8.9%	+9.2%	+31.1%
EBITDA	3.53B	3.16B	2.22B	4.17B
EBITDA Margin	+12.9%	+12.2%	+13.5%	+33.4%
EBT Excluding Unusual Items	2.14B	1.75B	1.38B	3.84B
Pretax Income	2.24B	1.78B	1.38B	4.29B
Operating Income	2.67B	2.29B	1.50B	3.88B
Operating Margin	+9.8%	+8.9%	+9.2%	+31.1%
Profit Margin	+7.3%	+6.6%	+5.9%	+29.8%
Net Income	2.00B	1.71B	0.96B	3.72B
Net Income to Common	2.00B	1.71B	0.96B	3.72B
Net Income Growth	+17.0%	+77.4%	-74.1%	—
Earnings From Continuing Ops.	2.02B	1.72B	0.96B	4.29B
Minority Interest in Earnings	-17.99M	-4.09M	-0.29M	-567.45M
Income Tax Expense	222.01M	62.04M	418.70M	—
Effective Tax Rate	+9.9%	+3.5%	+30.3%	—
Per Share & Capital
EPS (Basic)	0.18	0.15	0.10	0.38
EPS (Diluted)	0.18	0.15	0.10	0.38
EPS Growth	+17.0%	+60.3%	-74.6%	—
Dividend Per Share	—	0.03	—	—
Shares Change (YoY)	-0	0.11	0.02	—
Shares Outstanding (Basic)	11.11B	11.11B	10.04B	9.83B
Shares Outstanding (Diluted)	11.11B	11.11B	10.04B	9.83B
Free Cash Flow	3.99B	3.44B	2.14B	3.96B
Free Cash Flow Margin	+14.6%	+13.3%	+13.1%	+31.7%
Free Cash Flow Per Share	0.36	0.31	0.21	0.40
Payout Ratio	+17.5%	—	+31.1%	+82.2%
Supplemental
Other Unusual Items	0.80M	—	—	475.46M